BamSEC and AlphaSense Join Forces
Learn More

VivoSim Labs Inc.

NASDAQ: VIVS    
Share price (8/14/25): $1.80    
Market cap (8/14/25): $4.680 million

Material Contracts Filter

EX-10.1
from 8-K 5 pages Confidential
12/34/56
EX-10.29
from 10-K 12 pages The Plan Includes Two Components: A 423 Component and a Non-423 Component. the Company Intends (But Makes No Undertaking or Representation to Maintain) the 423 Component to Qualify as an Employee Stock Purchase Plan. the Provisions of the 423 Component, Accordingly, Will Be Construed in a Manner That Is Consistent With the Requirements of Section 423 of the Code. Except as Otherwise Provided in the Plan or Determined by the Board, the Non-423 Component Will Operate and Be Administered in the Same Manner as the 423 Component. (C) the Company, by Means of the Plan, Seeks to Retain the Services of Such Employees, to Secure and Retain the Services of New Employees and to Provide Incentives for Such Persons to Exert Maximum Efforts for the Success of the Company and Its Related Corporations. 2. Administration. (A) the Board or the Committee Will Administer the Plan. References Herein to the Board Shall Be Deemed to Refer to the Committee Except Where Context Dictates Otherwise. (B) the Board Will Have the Power, Subject To, and Within the Limitations Of, the Express Provisions of the Plan: (I) to Determine How and When Purchase Rights Will Be Granted and the Provisions of Each Offering (Which Need Not Be Identical)
12/34/56
EX-10.28
from 10-K 14 pages VivoSim Labs, Inc. Amended and Restated 2022 Equity Incentive Plan Global Restricted Stock Unit Award Agreement
12/34/56
EX-10.27
from 10-K 14 pages VivoSim Labs Inc. Amended and Restated 2022 Equity Incentive Plan Global Stock Option Award Agreement
12/34/56
EX-10.26
from 10-K 20 pages VivoSim Labs, Inc. Amended and Restated 2022 Equity Incentive Plan
12/34/56
EX-10.24
from 10-K 7 pages VivoSim Labs, Inc. Amended and Restated 2021 Inducement Equity Incentive Plan Restricted Stock Unit Agreement
12/34/56
EX-10.23
from 10-K 9 pages VivoSim Labs, Inc. Amended and Restated 2021 Inducement Equity Incentive Plan Stock Option Agreement
12/34/56
EX-10.22
from 10-K 13 pages VivoSim Labs, Inc. Amended and Restated 2021 Inducement Equity Incentive Plan
12/34/56
EX-10.7
from 10-K 13 pages ***Certain Identified Information Has Been Excluded From the Exhibit Because It Both (I) Is Not Material and (II) Is the Type That the Company Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit.*** License Agreement
12/34/56
EX-10.6
from 10-K 13 pages ***Certain Identified Information Has Been Excluded From the Exhibit Because It Both (I) Is Not Material and (II) Is the Type That the Company Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit.*** License Agreement
12/34/56
EX-10.1
from 10-K 17 pages VivoSim Labs, Inc. Amended and Restated 2012 Equity Incentive Plan (As Amended and Restated on April 24, 2025) 1. Purposes of the Plan. the Purposes of This Plan Are: • to Attract and Retain the Best Available Personnel for Positions of Substantial Responsibility; • to Provide Incentives to Individuals Who Perform Services for the Company; and • to Promote the Success of the Company’s Business
12/34/56
EX-10.2
from 8-K 3 pages Amendment No. 6 to Consulting Agreement
12/34/56
EX-10.1
from 8-K 26 pages Organovo Holdings, Inc. Amended and Restated 2022 Equity Incentive Plan (As Amended and Restated on November 20, 2024) 1. Purpose of the Plan. the Purpose of This Plan Is To: • to Attract and Retain the Best Available Personnel for Positions of Substantial Responsibility, • to Provide Additional Incentive to Employees, Directors and Consultants, and • to Promote the Success of the Company’s Business. the Plan Permits the Grant of Incentive Stock Options, Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units and Performance Shares. 2. Definitions. the Following Definitions Are Used in This Plan: (A) “Administrator” Means the Board or Any of Its Committees as Will Be Administering the Plan, in Accordance With Section 4 of the Plan
12/34/56
EX-10.2
from 8-K 22 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 21 pages Placement Agency Agreement
12/34/56
EX-10.42
from S-1/A 20 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 15 pages The Plan Includes Two Components: A 423 Component and a Non-423 Component. the Company Intends (But Makes No Undertaking or Representation to Maintain) the 423 Component to Qualify as an Employee Stock Purchase Plan. the Provisions of the 423 Component, Accordingly, Will Be Construed in a Manner That Is Consistent With the Requirements of Section 423 of the Code. Except as Otherwise Provided in the Plan or Determined by the Board, the Non-423 Component Will Operate and Be Administered in the Same Manner as the 423 Component. (C) the Company, by Means of the Plan, Seeks to Retain the Services of Such Employees, to Secure and Retain the Services of New Employees and to Provide Incentives for Such Persons to Exert Maximum Efforts for the Success of the Company and Its Related Corporations. 2. Administration. (A) the Board or the Committee Will Administer the Plan. References Herein to the Board Shall Be Deemed to Refer to the Committee Except Where Context Dictates Otherwise. (B) the Board Will Have the Power, Subject To, and Within the Limitations Of, the Express Provisions of the Plan: (I) to Determine How and When Purchase Rights Will Be Granted and the Provisions of Each Offering (Which Need Not Be Identical)
12/34/56
EX-10.1
from 8-K/A 7 pages Separation Agreement and General Release
12/34/56
EX-10.1
from 8-K 6 pages Separation Agreement and General Release
12/34/56
EX-10.38
from 10-K 88 pages Asset Purchase Agreement Acquisition of Certain Assets of Metacrine, Inc. by Organovo, Inc. Dated as of March 10, 2023
12/34/56